Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
12/2003
12/18/2003WO2002083030A3 Bifunctional energy-reversible acyl-compositions
12/18/2003WO2002057492A9 Methods and compositions for detecting polynucleotide duplex damage
12/18/2003US20030233085 Optimization of transcutaneous active permeation of compounds through the synergistic use of ultrasonically generated mechanical abrasion of the skin, chemical enhancers and simultaneous application of sonophoresis, iontophoresis, electroporation, mechanical vibrations and magnetophoresis through single application devices
12/18/2003US20030233045 Solid hydrogel coupling for ultrasound imaging and therapy
12/18/2003US20030232800 Non-symmetric tripyrranes in the synthesis of novel macrocycles
12/18/2003US20030232767 Activating cancerous cells response to therapeutic agents, by administering cisplatin or oxaliplatin, applying ionizing radiation and hydrogen peroxide
12/18/2003US20030232750 Indolicidin peptide analogues containing at least two basic amino acids; bactericide
12/18/2003CA2487413A1 Methods of treating angiogenesis, tumor growth, and metastasis
12/17/2003EP1371640A1 Novel a-lipoic acid derivative and use thereof
12/17/2003EP1371365A1 Emulsion/aggregation processes as methods for forming polymeric microspheres characterized by narrow particle size distribution for biomedical human and veterinary administration
12/17/2003EP1370253A2 METHOD FOR PROTECTING CELLS AND TISSUES FROM IONIZING RADIATION TOXICITY WITH $g(a), $g(b) UNSATURATED ARYL SULFONES
12/17/2003EP1370237A2 Presbyopia treatment by lens alteration
12/17/2003EP1079918B1 Microencapsulation and electrostatic processing method
12/17/2003CN1462197A Tumor treatment
12/16/2003US6664228 Photoselective marking of biological targets
12/16/2003US6664040 Complexing to polypeptides; antiproliferation agent
12/11/2003WO2003101530A2 Solid hydrogel coupling for ultrasound imaging and therapy
12/11/2003WO2003101486A2 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy
12/11/2003WO2003101451A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
12/11/2003WO2003035104A3 Compositions and methods for selected tumor treatment
12/11/2003WO2003003975A3 Detection and therapy of vulnerable plaque with photodynamic compounds
12/11/2003WO2002083067A3 Prodrugs via acylation with cinnamate
12/11/2003WO2002060383A3 Cancer therapy
12/11/2003US20030229283 Ultrasound therapy
12/11/2003US20030229147 Anticancer agents; triarylmethane dye
12/11/2003US20030229107 Magnetic resonance with stimulation
12/11/2003US20030229004 Modulation of tumor cells using BER inhibitors in combination with a sensitizing agent and DSBR inhibitors
12/11/2003US20030228644 Pro drugs for selective drug delivery
12/11/2003US20030228564 Nitric oxide in a pathogen inactivation process
12/11/2003CA2487757A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
12/11/2003CA2484515A1 Solid hydrogel coupling for ultrasound imaging and therapy
12/10/2003EP1369134A1 New agents for magnetic imaging method
12/10/2003EP1368057A2 Method to enhance the immunogenicity of an antigen
12/10/2003EP1368043A1 Blood brain barrier modulation using stressed autologous blood cells
12/10/2003EP1368038A1 Methods for the administration of amifostine and related compounds
12/09/2003US6662040 Methods of photoacoustic imaging
12/09/2003US6659107 Sensitization of cells with porphyrins, then exposing to radiation and grafting; photodynamic therapy
12/04/2003WO2003099716A1 Method of preparing aqueous fullerene solution or dispersion
12/04/2003WO2003099112A1 Microparticles having a matrix interior useful for ultrasound triggered delivery of drugs into the bloodstream
12/04/2003WO2003074002A3 Methods of treating pin1 associated disorders
12/04/2003WO2003061593A3 Novel targeted compositions for diagnostic and therapeutic use
12/04/2003WO2003050499A3 Use of a labeled ligand having human cd4 specificity
12/04/2003WO2002003850A8 Photoselective marking of biological targets
12/04/2003US20030225150 Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
12/04/2003US20030224002 Administering to a patient having a disorder associtaed with an intracellular pathogen, a molecular conjugate of a photosensitizer and a targeting moiety, wherein the targeting moiety targets conjugate to the pathogen or infected cell
12/04/2003US20030223958 Use of interleukin-19 to treat ovarian cancer
12/04/2003DE20310413U1 Vaccine, useful for treatment or prevention of infections or tumors, produced by inactivation with ultra-violet B radiation, retains antigenic structures while damaging nucleic acid
12/03/2003EP1365805A2 Novel targeted compositions for diagnostic and therapeutic use
12/03/2003CN1460099A Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
12/03/2003CN1129431C Combination of benzocyclobeptapyridine compounds and antineoplastic drugs for treating proliferative diseases
11/2003
11/27/2003WO2003097107A2 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
11/27/2003WO2003097096A1 Compositions and methods for delivery of photosensitive drugs
11/27/2003WO2003097095A1 Process for the preparation and activation of substances and a means of producing same
11/27/2003WO2003097044A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/27/2003WO2003078361B1 Controlling chemical reactions by spectral chemistry and spectral conditioning
11/27/2003WO2003004091A3 Aromatic sulfenates for type i phototherapy
11/27/2003US20030220563 Methods and apparatus for monitoring and quantifying the movement of fluid
11/27/2003US20030220313 Comprises estrogen/antiestrogen-porphyrin conjugate
11/27/2003US20030219420 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
11/27/2003US20030219379 Antiproliferative agent
11/27/2003US20030219354 Deactivation pathogens; using riboflavin sensitizers; exposure to light source
11/27/2003CA2486881A1 Process for the preparation and activation of substances and a means of producing same
11/27/2003CA2484324A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/27/2003CA2482458A1 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
11/26/2003EP1363667A1 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives
11/25/2003US6653337 Active ingredient mono-L-aspartyl chlorin e6 or mono-L-glutamyl chlorin e6 or salt
11/25/2003US6653327 Cross-regulin composition of tumeric-derived tetrahydrocurcuminoids for skin lightening and protection against UVB rays
11/20/2003WO2003095621A2 Apoptotic ebv-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferactive disorder
11/20/2003WO2003094979A1 Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
11/20/2003WO2003094939A1 Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
11/20/2003WO2003094936A1 Method for extended storage of blood and blood components
11/20/2003WO2003094929A2 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
11/20/2003WO2003094767A1 Methods of adjuvant photodynamic therapy to enhance radiation sensitization
11/20/2003WO2003065971A9 Non-myeloablative tolerogenic treatment with tyrphostins
11/20/2003WO2003061696A3 Systems and methods for photodynamic therapy
11/20/2003WO2003032984A8 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
11/20/2003WO2003028629A3 Chlorin photosensitizing agents for use in photodynamic therapy
11/20/2003US20030216795 Apparatus and method for high energy photodynamic therapy of acne vulgaris, seborrhea and other skin disorders
11/20/2003US20030216285 Selected from the group consisting of alloxazines and photosensitizers
11/20/2003US20030216284 Photoactivated drug therapy
11/20/2003US20030215784 Blood; endogenous alloxazines, vitamins K and L; 7,8-dimethyl-10-ribityl isoalloxazine (Riboflavin)
11/20/2003US20030215489 Chemosensitizing with liposomes containing oligonucleotides
11/20/2003US20030215459 Methods for promoting cell transfection in vivo
11/20/2003US20030215395 Cationic amine polymer, cationic peptide or cationic carbohydrate and at least one degradable linker molecule connecting said cationic molecules in a branched arrangement
11/20/2003US20030215394 Have a porous, gas-containing interior polymer matrix and a plurality of cavities in the matrix which contain a gas and the agent.
11/20/2003US20030215388 Can be administered in conjunction with radiation or chemotherapeutic agents.
11/20/2003CA2483046A1 Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
11/19/2003EP1362598A1 Active oxygen generator containing photosensitizer for ultrasonic therapy
11/19/2003EP1361899A2 Devices and methods for the treatment of cancer
11/19/2003EP0967997B1 Pharmaceutical composition for eliminating membrane-mediated cell resistance
11/19/2003EP0756477B1 Methods for phototherapeutic treatment of proliferative skin diseases
11/18/2003US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
11/18/2003US6649383 Yeast cells cultured in presence of alternating electric field of given frequency and strength; increases secretion of gastric juice and alleviates ulcer
11/18/2003US6649193 Biomedically acceptable, cage-like compounds, including cobalamin (vitamin B12), potassium silicate and colloidal silicates and aluminosilicates such as zeolites encage atomic hydrogen in a
11/13/2003WO2003092746A1 Fluid mixing and irradiation device and method of using the device especially for biological fluids
11/13/2003WO2003092691A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
11/13/2003WO2003092683A1 Epothilone derivative for the treatment of hepatoma and other cancer diseases
11/13/2003WO2003092623A2 Calicheamicin derivative-carrier conjugates
11/13/2003WO2003052060A3 Beta-cyclodextrin dimers and phthalocyanines and uses thereof
11/13/2003WO2003022360A3 Thermotherapy via targeted delivery of nanoscale magnetic particles
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 95